Is LifeVantage Corp. overvalued or undervalued?
As of June 27, 2025, LifeVantage Corp. is considered fairly valued with a P/E ratio of 17, strong growth potential indicated by a PEG ratio of 0.11, and impressive returns, having outperformed the S&P 500 with a 94.63% return over the past year, despite a recent stock price decline.
As of 27 June 2025, the valuation grade for LifeVantage Corp. has moved from very attractive to attractive, indicating a shift in perception regarding its value. The company is currently assessed as fairly valued. Key ratios include a P/E ratio of 17, an EV to EBITDA of 8.48, and a PEG ratio of 0.11, which suggests strong growth potential relative to its price.In comparison to peers, LifeVantage Corp. has a P/E ratio that is lower than Chromadex Corp. at 67.47 and slightly higher than USANA Health Sciences, Inc. at 16.29. The company's high ROCE of 96.19% and ROE of 26.91% further underscore its efficient capital utilization. Despite a recent decline in stock price, the company has outperformed the S&P 500 over the past year with a return of 94.63% compared to 12.59% for the index, reinforcing its attractiveness in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
